DuPont de Nemours, Inc.
$DD stock movements created a mixed sentiment among investors and analysts. While some investors have reduced their holdings, others have acquired additional stakes. The company's shares were sold by multiple investment firms including
Allstate Corp,
Caisse DE Depot ET Placement DU Quebec,
Candriam S.C.A.,
Erste Asset Management, and
Dorsey & Whitney Trust. Conversely, entities like
1832 Asset Management,
AlphaQuest LLC,
Price T Rowe Associates Inc.,
CW Advisors LLC,
Nuveen LLC, and
Vanguard Group Inc. increased their respective positions in DuPont stock. The stock's price target was set at
$88.25. Depicting a strong footing among institutional investors, 72% of the company is owned by these investors. In addition to this, DuPont announced the finalization of a
$1.8 billion deal with Arclin, Inc. to sell its Aramids business, while maintaining a strategic stake in the combined entity. Moreover, DuPont has reported solid earnings growth and has raised its guidance for 2025. It also initiated a massive
$1.75 billion financing deal for spinning off its electronics business. Nevertheless, the stock has seen a decline of 7.7% since its last earnings report prompting caution due to weak technical signals.
Dupont De Nemours DD News Analytics from Wed, 22 Jan 2025 08:00:00 GMT to Sat, 30 Aug 2025 22:31:36 GMT -
Rating 2
- Innovation 3
- Information 4
- Rumor -5
